Literature DB >> 4901345

Use of antilymphocyte globulin after cadaveric renal transplantation.

P B Doak, N T Dalton, J Meredith, J Z Montgomerie, J D North.   

Abstract

Antilymphocyte globulin (A.L.G.) was prepared by injecting fresh frozen splenic cells subcutaneously into horses. The IgG fraction of the serum was concentrated by a batch technique using diethylaminoethanol-Sephadex. Fourteen patients given this material by intramuscular injection after cadaveric renal transplants, in addition to azathioprine and prednisone, had less evidence of rejection compared with patients previously treated with azathioprine and prednisone only, despite a reduction of the mean daily prednisone dose from 65 to 45 mg. Toxicity, especially local reaction, fever, and hypotension, limited the amount of A.L.G. that was given.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4901345      PMCID: PMC1630331          DOI: 10.1136/bmj.4.5682.522

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  15 in total

1.  Testing of anti-human lymphocyte sera in chimpanzees and lower primates.

Authors:  H Balner; V P Eysvoogel; F J Cleton
Journal:  Lancet       Date:  1968-01-06       Impact factor: 79.321

2.  Assay for the immunosuppressive capacity of antilymphocyte serum based on its action on thymus-derived cells.

Authors:  W J Martin; J F Miller
Journal:  Int Arch Allergy Appl Immunol       Date:  1969

3.  Survival of skin heterografts under treatment with antilymphocytic serum.

Authors:  E M Lance; P B Medawar
Journal:  Lancet       Date:  1968-06-01       Impact factor: 79.321

4.  Renal transplantation in man. Experience in 35 cases.

Authors:  M F Woodruff; B Nolan; J S Robson; M K MacDonald
Journal:  Lancet       Date:  1969-01-04       Impact factor: 79.321

5.  Clinical reactions and serologic changes after the administration of heterologous antilymphocyte globulin to human recipients of renal homografts.

Authors:  N Kashiwagi; C O Brantigan; L Brettschneider; C G Groth; T E Starzl
Journal:  Ann Intern Med       Date:  1968-02       Impact factor: 25.391

6.  Immunosuppression with antilymphocyte globulin in clinical renal transplantation.

Authors:  K Konomi; S D Deodhar; K S Tung; S Nakamoto
Journal:  Surg Forum       Date:  1968

7.  Studies on the mode of action of heterologous anti-lymphocyte plasma. II. The effect of anti-lymphocyte plasma on lymphocyte counts.

Authors:  H F Jeejeebhoy; J M Vela-Martinez
Journal:  Transplantation       Date:  1968-03       Impact factor: 4.939

Review 8.  Anti-lymphocytic antibody--a review.

Authors:  K James
Journal:  Clin Exp Immunol       Date:  1967-11       Impact factor: 4.330

9.  Microtiter modification of th complement fixation test for platelet antibodies.

Authors:  E Howell; H A Perkins
Journal:  Transfusion       Date:  1968 Jan-Feb       Impact factor: 3.157

10.  [Therapeutic effect of heterologous antihuma lymphocyte serum (AHLS) in chronic lympahtic leukemia].

Authors:  A D Tsirimbas; R Pichlmayr; B Hornung; H Pfisterer; S Thierfelder; W Brendel; W Stich
Journal:  Klin Wochenschr       Date:  1968-06-01
View more
  3 in total

1.  Antilymphocytic serum--the possible clinical applications.

Authors:  M H Lessof
Journal:  Proc R Soc Med       Date:  1970-09

2.  Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY).

Authors:  T E Starzl; K A Porter; G Andres; C G Halgrimson; R Hurwitz; G Giles; P I Terasaki; I Penn; G T Schroter; J Lilly; S J Starkie; C W Putnam
Journal:  Ann Surg       Date:  1970-09       Impact factor: 12.969

3.  The mode of action of cytotoxic drugs.

Authors:  M C Berenbaum
Journal:  Proc R Soc Med       Date:  1970-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.